NKX3-1 rs11781886: What Your Genotype Means
The rs11781886 variant is a single nucleotide polymorphism located in the NKX3-1 gene, which encodes a protein essential for prostate development and tumor suppression. Research suggests this variant may influence prostate cancer susceptibility by altering the expression levels of the NKX3-1 gene.
What each genotype means
Typical NKX3-1 expression
This genotype is associated with higher transcriptional activity of the NKX3-1 gene compared to the G allele. Research suggests that individuals with this genotype may have higher levels of NKX3-1 expression in prostate tissue, which is generally considered protective against prostate cancer susceptibility.
This is the non-susceptible genotype, which is common in many global populations.
Intermediate NKX3-1 expression
Carrying one copy of the G allele may result in intermediate levels of NKX3-1 expression. Some studies indicate that the G allele is associated with reduced binding of the transcription factor Sp1, potentially lowering NKX3-1 expression and increasing prostate cancer susceptibility compared to the AA genotype.
This heterozygous genotype is found at varying frequencies across different ancestral groups.
Reduced NKX3-1 expression
This genotype is associated with lower transcriptional activity of the NKX3-1 gene in the prostate. Research suggests this variant may increase susceptibility to prostate cancer and, in some studies, has been linked to poorer clinical outcomes; however, these associations are complex and may be influenced by other factors like diet or antioxidant intake.
The G allele is less common than the A allele in many populations, making this homozygous genotype relatively infrequent.
Understanding the rs11781886 Variant
The rs11781886 variant is a specific genetic change located in the 5'-untranslated region (5'-UTR) of the NKX3-1 gene on chromosome 8. In genetics, a single nucleotide polymorphism (SNP) represents a variation at a single position in the DNA sequence. Because this variant sits in the 5'-UTR, it is positioned in a regulatory area that helps control how much of the NKX3-1 protein is produced. Scientific studies have indicated that this specific site can affect the binding affinity of transcription factors, such as Sp1, which are proteins that turn genes on or off. When the binding affinity is altered, it can lead to changes in the transcriptional activity of the gene, potentially resulting in lower levels of the NKX3-1 protein within prostate cells.
The Role of the NKX3-1 Gene
The NKX3-1 gene is a well-characterized tumor suppressor gene that is primarily expressed in the prostate. It plays a critical role in maintaining the health of prostate epithelial cells by regulating cell growth, differentiation, and the prevention of DNA damage. By acting as a 'gatekeeper,' the NKX3-1 protein helps ensure that prostate cells function normally and do not proliferate uncontrollably. When the expression of this gene is reduced, the protective mechanisms it provides are weakened, which may create an environment more conducive to the development of prostate cancer. Because of its central role in prostate biology, variations that influence its expression, such as rs11781886, have been the subject of significant investigation to determine their impact on long-term prostate health and cancer risk.
Research and Evidence Strength
The association between rs11781886 and prostate cancer is supported by various studies, though the evidence is considered limited in terms of clinical predictive power. Research has shown that the allele associated with susceptibility can lead to decreased NKX3-1 expression, which is a known factor in prostate tumor development. Some studies have also explored whether this variant, either alone or in combination with other genetic markers, correlates with disease prognosis or recurrence. However, it is important to note that genetic susceptibility is complex and influenced by many factors, including environment and other genes. While the biological mechanism—the down-regulation of a tumor suppressor—is well-documented, the variant's individual impact on a person's overall risk remains a subject of ongoing research rather than a definitive diagnostic tool.
What This Information Means for You
If you have received information about your rs11781886 genotype, it is important to view it in the context of your overall health. This variant is one of many factors that may contribute to prostate cancer risk, and having a specific genotype does not mean you will develop the disease. Genetic testing for this SNP is not a substitute for standard medical screenings, such as prostate-specific antigen (PSA) tests or clinical exams recommended by your healthcare provider. You cannot use this information to diagnose yourself or to make independent medical decisions. If you are concerned about your prostate health or family history, the most effective step is to discuss your concerns with a physician or a genetic counselor. They can help you interpret your results alongside other clinical factors and guide you toward appropriate, evidence-based health management strategies.
How common is this variant?
The frequency of the rs11781886 variant varies significantly across different ancestral populations, with specific allele distributions documented in various global genetic studies.
Frequently asked questions
Does having the rs11781886 variant mean I will get prostate cancer?
No. This variant is associated with a statistical change in susceptibility, not a direct cause of cancer. Many other genetic and environmental factors contribute to prostate cancer risk.
Should I get tested for this SNP?
Genetic testing for this variant is not currently part of standard clinical care. If you are concerned about prostate cancer, consult your doctor about established screening methods like PSA testing.
Can I change my gene expression if I have the 'GG' genotype?
There is no known way to 'fix' or change your genotype. However, maintaining a healthy lifestyle and following medical advice for regular screenings are the best ways to manage your overall health.
Is this variant the same as a mutation?
In this context, it is a common genetic variation (polymorphism) rather than a rare, high-penetrance mutation. It is a normal part of human genetic diversity that happens to be associated with disease risk.
Sources & further reading
Educational information only, last refreshed 10/30/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs11781886?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29